SCHEMBL4975417

SCHEMBL4975417

CCC[C@](OCCNC(=O)OC)(c1cccc(Cl)c1)C1CCCN(C(=O)O)C1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.49
CYP3A4 P08684 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3615894 0.90 REN (0.48) RENCYP3A4
SCHEMBL3615891 0.90 REN (0.48) RENCYP3A4
SCHEMBL27737826 0.87 REN (0.42) REN
SCHEMBL4971952 0.87 REN (0.42) REN
SCHEMBL4973588 0.86 REN (0.49) RENCYP3A4
SCHEMBL4974456 0.84 REN (0.40) REN
SCHEMBL3606066 0.83 REN (0.75) RENCYP3A4
SCHEMBL9996444 0.83 REN (0.75) RENCYP3A4
SCHEMBL9996264 0.83 REN (0.75) RENCYP3A4
SCHEMBL27758544 0.81 REN (0.69) RENCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed